Back to search
Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).
Data up to Jan 2025
Published2015
Citations67
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database